3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, B-Cell
6
Recurrence
4
Lymphoma, Mantle-Cell
3
Lymphoma
3
Burkitt Lymphoma
3
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Leukemia, B-Cell
2
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
34
Etoposide
25
Doxorubicin
20
Carboplatin
20
Vincristine
19
Isotretinoin
19
Topotecan
17
Temozolomide
17
Irinotecan
16
Filgrastim
16
Melphalan
15
Cisplatin
15
sargramostim
14
Radiotherapy
14
Granulocyte-Macrophage Colony-Stimulating Factor
13
3-Iodobenzylguanidine
12
dinutuximab
11
Peripheral Blood Stem Cell Transplantation
11
naxitamab
9
Thiotepa
9
Magnetic Resonance Spectroscopy
9
humanized 3F8 anti-GD2 monoclonal antibody
7
Granulocyte Colony-Stimulating Factor
7
Busulfan
7
X-Rays
6
Specimen Handling
6
Phantoms, Imaging
6
Ifosfamide
6
Antilymphocyte Serum
6
fludarabine phosphate
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neuroblastoma
×
Immunotherapy, Adoptive
×
Clear all
NCT02100891
2025-03-19
STIR
Medical College of Wisconsin
Phase 2
Terminated
15 enrolled
11 charts